{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:30Z","timestamp":1788782910680,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08250-7","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:06:18Z","timestamp":1779426378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DUSP4-mediated dephosphorylation of PSMD14 enhances PSMD14-dependent deubiquitination of MICALL2 and promotes malignant progression in clear cell renal cell carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Xian-you","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-shui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4093-4622","authenticated-orcid":false,"given":"Lie-fu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"4","key":"8250_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17(4):245\u201361.","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"8250_CR2","doi-asserted-by":"publisher","first-page":"9276","DOI":"10.3390\/curroncol30100670","volume":"30","author":"G Pezzicoli","year":"2023","unstructured":"Pezzicoli G, et al. Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma. Curr Oncol. 2023;30(10):9276\u201390.","journal-title":"Curr Oncol"},{"issue":"1","key":"8250_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semnephrol.2019.12.004","volume":"40","author":"JJ Huang","year":"2020","unstructured":"Huang JJ, Hsieh JJ. The Therapeutic Landscape of Renal Cell Carcinoma: From the Dark Age to the Golden Age. Semin Nephrol. 2020;40(1):28\u201341.","journal-title":"Semin Nephrol"},{"issue":"Pt 2","key":"8250_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.semcancer.2020.03.008","volume":"67","author":"T Bonacci","year":"2020","unstructured":"Bonacci T, Emanuele MJ. Dissenting degradation: Deubiquitinases in cell cycle and cancer. Semin Cancer Biol. 2020;67(Pt 2):145\u201358.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"8250_CR5","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1002\/1878-0261.13076","volume":"15","author":"T Sun","year":"2021","unstructured":"Sun T, et al. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2. Mol Oncol. 2021;15(12):3639\u201358.","journal-title":"Mol Oncol"},{"key":"8250_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2019.10.025","volume":"469","author":"J Lv","year":"2020","unstructured":"Lv J, et al. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2. Cancer Lett. 2020;469:22\u201334.","journal-title":"Cancer Lett"},{"issue":"6","key":"8250_CR7","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.7150\/thno.48375","volume":"11","author":"C Jing","year":"2021","unstructured":"Jing C, et al. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1\/Akt\/SOX2-mediated stemness. Theranostics. 2021;11(6):2655\u201369.","journal-title":"Theranostics"},{"issue":"2","key":"8250_CR8","doi-asserted-by":"publisher","first-page":"113148","DOI":"10.1016\/j.yexcr.2022.113148","volume":"415","author":"J Li","year":"2022","unstructured":"Li J, et al. Deubiquitinating enzyme PSMD14 facilitates gastric carcinogenesis through stabilizing PTBP1. Exp Cell Res. 2022;415(2):113148.","journal-title":"Exp Cell Res"},{"key":"8250_CR9","doi-asserted-by":"crossref","unstructured":"Xia T et al. Comprehensive Analysis of MICALL2 Reveals Its Potential Roles in EGFR Stabilization and Ovarian Cancer Cell Invasion. Int J Mol Sci, 2023. 25(1).","DOI":"10.3390\/ijms25010518"},{"issue":"10","key":"8250_CR10","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1128\/MCB.00144-08","volume":"28","author":"H Nakatsuji","year":"2008","unstructured":"Nakatsuji H, et al. Involvement of actinin-4 in the recruitment of JRAB\/MICAL-L2 to cell-cell junctions and the formation of functional tight junctions. Mol Cell Biol. 2008;28(10):3324\u201335.","journal-title":"Mol Cell Biol"},{"key":"8250_CR11","doi-asserted-by":"publisher","first-page":"109730","DOI":"10.1016\/j.abb.2023.109730","volume":"747","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. MICALL2 participates in the regulation of epithelial-mesenchymal transition in alveolar epithelial cells - Potential roles in pulmonary fibrosis. Arch Biochem Biophys. 2023;747:109730.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"8250_CR12","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.7150\/jca.66922","volume":"13","author":"W Lin","year":"2022","unstructured":"Lin W, et al. Identification of MICALL2 as a Novel Prognostic Biomarker Correlating with Inflammation and T Cell Exhaustion of Kidney Renal Clear Cell Carcinoma. J Cancer. 2022;13(4):1214\u201328.","journal-title":"J Cancer"},{"issue":"1","key":"8250_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.33160\/yam.2023.02.021","volume":"66","author":"X Zeng","year":"2023","unstructured":"Zeng X, et al. Micall2 Is Responsible for the Malignancy of Clear Cell Renal Cell Carcinoma. Yonago Acta Med. 2023;66(1):171\u20139.","journal-title":"Yonago Acta Med"},{"issue":"1","key":"8250_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12964-022-00984-3","volume":"20","author":"P Wen","year":"2022","unstructured":"Wen P, et al. MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer. Cell Commun Signal. 2022;20(1):170.","journal-title":"Cell Commun Signal"},{"key":"8250_CR15","doi-asserted-by":"crossref","unstructured":"Chen HF, Chuang HC, Tan TH. Regulation of Dual-Specificity Phosphatase (DUSP) Ubiquitination and Protein Stability. Int J Mol Sci, 2019. 20(11).","DOI":"10.3390\/ijms20112668"},{"key":"8250_CR16","doi-asserted-by":"publisher","first-page":"102016","DOI":"10.1016\/j.tranon.2024.102016","volume":"46","author":"X Wang","year":"2024","unstructured":"Wang X, et al. DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB. Transl Oncol. 2024;46:102016.","journal-title":"Transl Oncol"},{"issue":"5","key":"8250_CR17","doi-asserted-by":"publisher","first-page":"112445","DOI":"10.1016\/j.celrep.2023.112445","volume":"42","author":"L Zhou","year":"2023","unstructured":"Zhou L, et al. DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90\u03b2. Cell Rep. 2023;42(5):112445.","journal-title":"Cell Rep"},{"issue":"8","key":"8250_CR18","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/bbb\/zbab111","volume":"85","author":"X Zeng","year":"2021","unstructured":"Zeng X, Zhu C, Zhu X. DUSP4 promotes the carcinogenesis of CCRCC via negative regulation of autophagic death. Biosci Biotechnol Biochem. 2021;85(8):1839\u201345.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"8250_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1021\/pr100985s","volume":"10","author":"JR McLean","year":"2011","unstructured":"McLean JR, Kouranti I, Gould KL. Survey of the phosphorylation status of the Schizosaccharomyces pombe deubiquitinating enzyme (DUB) family. J Proteome Res. 2011;10(3):1208\u201315.","journal-title":"J Proteome Res"},{"issue":"6119","key":"8250_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1126\/science.1230161","volume":"339","author":"A Ernst","year":"2013","unstructured":"Ernst A, et al. A strategy for modulation of enzymes in the ubiquitin system. Science. 2013;339(6119):590\u20135.","journal-title":"Science"},{"issue":"11","key":"8250_CR21","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/embor.2009.192","volume":"10","author":"R Hjerpe","year":"2009","unstructured":"Hjerpe R, et al. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 2009;10(11):1250\u20138.","journal-title":"EMBO Rep"},{"issue":"1","key":"8250_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred R, et al. The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 2021;30(1):187\u2013200.","journal-title":"Protein Sci"},{"key":"8250_CR23","unstructured":"Bahadoram S, et al. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. Volume 39. G Ital Nefrol; 2022. 3."},{"key":"8250_CR24","doi-asserted-by":"crossref","unstructured":"Stolpa W, Str\u0119k-Cholewi\u0144ska A, Mizia-Malarz A. Clear Cell Ren Cell Carcinoma Diagn Therapeutic Difficulties Case Rep Literature Rev Med (Kaunas), 2022. 58(10).","DOI":"10.3390\/medicina58101329"},{"issue":"17","key":"8250_CR25","first-page":"3413","volume":"39","author":"MM Wolf","year":"2020","unstructured":"Wolf MM, Rathmell WK, Beckermann KE. Modeling clear cell Ren cell carcinoma therapeutic implications Oncogene. 2020;39(17):3413\u201326.","journal-title":"Modeling clear cell Ren cell carcinoma therapeutic implications Oncogene"},{"issue":"1","key":"8250_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19(1):146.","journal-title":"Mol Cancer"},{"key":"8250_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ebiom.2019.10.039","volume":"49","author":"D Seo","year":"2019","unstructured":"Seo D, et al. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway. EBioMedicine. 2019;49:55\u201371.","journal-title":"EBioMedicine"},{"issue":"10","key":"8250_CR28","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.7150\/jca.39539","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, et al. Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance. J Cancer. 2020;11(10):2962\u201371.","journal-title":"J Cancer"},{"key":"8250_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2018.01.025","volume":"418","author":"R Zhu","year":"2018","unstructured":"Zhu R, et al. Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma. Cancer Lett. 2018;418:125\u201334.","journal-title":"Cancer Lett"},{"issue":"2","key":"8250_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.apsb.2020.09.007","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Phosphorylation regulates cullin-based ubiquitination in tumorigenesis. Acta Pharm Sin B. 2021;11(2):309\u201321.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"8250_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1096\/fasebj.14.1.6","volume":"14","author":"M Camps","year":"2000","unstructured":"Camps M, Nichols A, Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. Faseb j. 2000;14(1):6\u201316.","journal-title":"Faseb j"},{"issue":"12","key":"8250_CR32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1134\/S0006297921120117","volume":"86","author":"J Han","year":"2021","unstructured":"Han J, et al. Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4. Biochem (Mosc). 2021;86(12):1624\u201334.","journal-title":"Biochem (Mosc)"},{"issue":"55","key":"8250_CR33","doi-asserted-by":"publisher","first-page":"94028","DOI":"10.18632\/oncotarget.21522","volume":"8","author":"X Kang","year":"2017","unstructured":"Kang X, et al. DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition. Oncotarget. 2017;8(55):94028\u201339.","journal-title":"Oncotarget"},{"issue":"1","key":"8250_CR34","doi-asserted-by":"publisher","first-page":"2409054","DOI":"10.1080\/20565623.2024.2409054","volume":"10","author":"SY Dong","year":"2024","unstructured":"Dong SY, et al. The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis. Future Sci OA. 2024;10(1):2409054.","journal-title":"Future Sci OA"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08250-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08250-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08250-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:29:21Z","timestamp":1781864961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08250-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8250"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08250-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval from the Scientific Research Ethics Committee of Jinggangshan University Affiliated Hospital was granted for handling clinical samples. Experimental procedures received approval from Animal Research Ethics Committee of the Scientific Research Ethics Committee of Jinggangshan University Affiliated Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"790"}}